Long WJ - Search Results

1

Neutralizing monoclonal antibodies to hepatitis A virus: partial localization of a neutralizing antigenic site.

Hughes JV, Stanton LW, Tomassini JE, Long WJ, Scolnick EM. Hughes JV, et al. Among authors: long wj. J Virol. 1984 Nov;52(2):465-73. doi: 10.1128/JVI.52.2.465-473.1984. J Virol. 1984. PMID: 6208377 Free PMC article.

2

Isolation of a monoclonal antibody that blocks attachment of the major group of human rhinoviruses.

Colonno RJ, Callahan PL, Long WJ. Colonno RJ, et al. Among authors: long wj. J Virol. 1986 Jan;57(1):7-12. doi: 10.1128/JVI.57.1.7-12.1986. J Virol. 1986. PMID: 3001366 Free PMC article.

3

[Molecular mechanism of Xinyang Tablets in improving myocardial fibrosis in uremic cardiomyopathy based on single-cell sequencing technology].

Ni SH, Li ZR, Li SJ, He XL, Li J, Chen XL, Long WJ, Zhang WW, Liao HL, Lu L, Yang ZQ. Ni SH, et al. Among authors: long wj. Zhongguo Zhong Yao Za Zhi. 2024 Dec;49(24):6746-6754. doi: 10.19540/j.cnki.cjcmm.20240730.401. Zhongguo Zhong Yao Za Zhi. 2024. PMID: 39805763 Chinese.

4

Advances in the management of arteriosclerosis of the lower extremity: Integrating Western and Chinese medicine approaches.

Cheng S, Xu JX, Long WJ. Cheng S, et al. Among authors: long wj. World J Clin Cases. 2024 Dec 26;12(36):6871-6876. doi: 10.12998/wjcc.v12.i36.6871. World J Clin Cases. 2024. PMID: 39726921 Free PMC article.

5

Advancing cardiovascular outcomes with dapagliflozin and sacubitril in post-acute myocardial infarction heart failure and type 2 diabetes mellitus.

Liu DH, Dong XM, Long WJ. Liu DH, et al. Among authors: long wj. World J Clin Cases. 2024 Dec 26;12(36):6935-6938. doi: 10.12998/wjcc.v12.i36.6935. World J Clin Cases. 2024. PMID: 39726920 Free PMC article.

6

Effects of atrial septal defects on the cardiac conduction system.

Kang JH, Wu HY, Long WJ. Kang JH, et al. Among authors: long wj. World J Clin Cases. 2024 Dec 16;12(35):6770-6774. doi: 10.12998/wjcc.v12.i35.6770. World J Clin Cases. 2024. PMID: 39687649 Free PMC article.

7

Hidden costs of first choice alternatives: A financial model of thromboprophylaxis and prosthetic joint infection prophylaxis in total knee arthroplasty.

Bergstein VE, Taylor WL 4th, Weinblatt AI, Long WJ. Bergstein VE, et al. Among authors: long wj. J Orthop. 2024 Nov 1;63:87-92. doi: 10.1016/j.jor.2024.10.053. eCollection 2025 May. J Orthop. 2024. PMID: 39564092

8

The Use of Aspirin for Venous Thromboembolism Prophylaxis in Patients Who Have Morbid Obesity Undergoing Primary and Revision Total Joint Arthroplasty.

Torres-Ramirez RJ, Escalera C, Cushner FD, Long WJ, Rodriguez JA. Torres-Ramirez RJ, et al. Among authors: long wj. J Arthroplasty. 2024 Oct;39(10):2413-2420. doi: 10.1016/j.arth.2024.05.053. Epub 2024 May 24. J Arthroplasty. 2024. PMID: 38797448

9

Mini-Navigation Utilization in THA Results in Shorter Length of Stay, Increased Home Discharge, and Higher Physical Therapy Mobilization Scores Compared to THA Without Navigation.

Wang C, Mahure SA, Kirschner N, Feng JE, Schwarzkopf R, Long WJ. Wang C, et al. Among authors: long wj. Bull Hosp Jt Dis (2013). 2024 Jun;82(2):134-138. Bull Hosp Jt Dis (2013). 2024. PMID: 38739661

10

Impact of Selective Posterior Cruciate Ligament Fiber Release on Femoral Rollback in Cruciate-Retaining Total Knee Arthroplasty: A Computational Study.

Pourmodheji R, Chalmers BP, Debbi EM, Long WJ, Wright TM, Westrich GH, Mayman DJ, Imhauser CW, Sculco PK, Kahlenberg CA. Pourmodheji R, et al. Among authors: long wj. J Arthroplasty. 2024 Aug;39(8S1):S347-S352.e2. doi: 10.1016/j.arth.2024.03.072. Epub 2024 Apr 9. J Arthroplasty. 2024. PMID: 38599529

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

219 results

Search Page

Filters